A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant ...
GRIN2A gene mutations emerge as single-gene cause of childhood schizophrenia, anxiety, and mood disorders, potentially ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
India Today on MSN
Why sugar cravings reduce as you grow older
Sugar cravings naturally reduce as people grow older. This happens not just because of food preferences but also biological ...
Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...
Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success. | Zealand Pharma may be ...
Saffron is a spice high in antioxidants and anti-inflammatory compounds. It may have benefits for mood, cognitive function, heart health, and more.
Is it bad to have a cup of coffee with breakfast? Not at all. Scientific studies have been highlighting the benefits of this ...
Body Network on MSN
I'm a neurology nurse and here are 5 things Ozempic is doing to your brain right now
A neurology nurse explains what we’re learning about Ozempic, GLP-1s, mood, cravings, brain fog, and long-term risks.
A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback